Results 91 to 100 of about 1,814 (132)

Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]

Clin Ophthalmol
Itoh K, Negishi M.
europepmc   +1 more source

Anti-vascular endothelial growth factors in retinal and choroidal diseases - Present landscape. [PDF]

Indian J Ophthalmol
Kannan NB, Vallinayagam M, Rishitha K, Ramasamy K.   +3 more
europepmc   +1 more source

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. [PDF]

Sci Rep
Thunwiriya P, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V, Chanarat S, Pakotiprapha D, Hanutsaha P.   +10 more
europepmc   +1 more source

TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration. [PDF]

Eye (Lond)
Regillo C, Kaiser PK, Kertes PJ, Gillies M, Maio-Twofoot T, Lawrence D, Holz FG.   +6 more
europepmc   +1 more source

Increased aqueous flare after intravitreal brolucizumab injections compared to aflibercept in neovascular age-related macular degeneration. [PDF]

Graefes Arch Clin Exp Ophthalmol
Hashimoto Y, Arai Y, Takahashi H, Tampo H, Kondo R, Takahashi H, Yoshida H, Takahashi R, Inoda S, Kaburaki T, Yanagi Y.   +10 more
europepmc   +1 more source

Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotype. [PDF]

Sci Rep
Fukuda Y, Sakurada Y, Kotoda Y, Kikushima W, Kashiwagi K.   +4 more
europepmc   +1 more source

Faricimab for Diabetic Macular Edema in Eyes Vitrectomized for Proliferative Diabetic Retinopathy: A 12-Month Retrospective Study. [PDF]

J Clin Med
Yoon K, Usui-Ouchi A, Sakanishi Y, Ebihara N, Nakao S.   +4 more
europepmc   +1 more source

Shaping the future of retinal care in India: Anti-VEGF therapy now and beyond. [PDF]

Indian J Ophthalmol
Karpe A, Narula R, Shroff D, Roy A.
europepmc   +1 more source

Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan from 2017 to 2022: An analysis of the NDB Open Data. [PDF]

PLoS One
Kabata Y, Terauchi R, Nakano T.
europepmc   +1 more source